Keyphrases
Cancer Tissue
20%
Cell Cycle Progression
40%
Cell Proliferation
20%
Dysregulation
40%
Extracellular nucleotides
40%
Hepatocellular Carcinoma
60%
Hepatocellular Carcinoma Cells
100%
Hepatocellular Carcinoma Patients
100%
Hyperproliferative
20%
JNK Pathway
20%
Liver
20%
Liver Carcinoma Cells
20%
Liver Tumor
20%
New Targets
20%
P2 Purinergic Receptors
80%
P2X3
100%
P2X3 Receptor
20%
P2Y13
20%
Pathophysiologic
20%
Patient Cohort
20%
Primary Hepatocytes
20%
Purinergic Receptors
100%
Purinergic Signaling
60%
Receptor Expression
60%
Receptor Isoforms
20%
Receptor Overexpression
100%
Recurrence-free Survival
100%
Targets for Therapy
20%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Liver Tumor
8%
Malignant Neoplasm
8%
Purinergic P2 Receptor
33%
Purinergic P2X3 Receptor
100%
Recurrence Free Survival
100%